Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-28 4:44 pm Purchase | 2026-06-30 | 13G | DAMORA THERAPEUTICS, INC DMRA | BlackRock, Inc. BLK | 3,143,576 5.100% | 3,143,576 (New Position) | Filing History |
| 2026-05-15 4:20 pm Purchase | 2026-03-31 | 13G | DAMORA THERAPEUTICS, INC DMRA | Point72 Asset Management, L.P. | 1,193,708 2.000% | 1,093,707 (+1093.70%) | Filing History |
| 2026-05-15 4:16 pm Sale | 2026-03-31 | 13G | DAMORA THERAPEUTICS, INC DMRA | Jain Global LLC | 0 0.000% | -120,566 (Position Closed) | Filing History |
| 2026-05-15 08:16 am Purchase | 2026-03-31 | 13G | DAMORA THERAPEUTICS, INC DMRA | Avoro Capital Advisors LLC | 3,783,000 6.270% | 3,783,000 (New Position) | Filing History |
| 2026-04-23 9:22 pm Purchase | 2026-02-09 | 13G | DAMORA THERAPEUTICS, INC DMRA | Paramora Holding LLC | 2,045,473 3.390% | 1,925,000 (+1597.87%) | Filing History |
| 2026-04-23 9:19 pm Purchase | 2026-02-09 | 13G | DAMORA THERAPEUTICS, INC DMRA | Paragon Therapeutics, Inc. | 2,045,473 3.390% | 1,925,000 (+1597.87%) | Filing History |
| 2026-03-06 4:43 pm Purchase | 2026-02-28 | 13G | GALECTO INC GLTO | Ikarian Capital, LLC | 335,710 0.600% | 50,000 (+17.50%) | Filing History |
| 2026-02-17 7:17 pm Purchase | 2026-02-09 | 13G | DAMORA THERAPEUTICS, INC DMRA | Venrock Healthcare Capital Partners III, L.P. | 3,603,595 6.000% | 3,603,595 (New Position) | Filing History |
| 2026-02-17 4:35 pm Purchase | 2025-12-31 | 13G | DAMORA THERAPEUTICS, INC DMRA | Jain Global LLC | 120,566 7.500% | 120,566 (New Position) | Filing History |
| 2026-02-11 6:11 pm Purchase | 2026-02-09 | 13D | DAMORA THERAPEUTICS, INC DMRA | Fairmount Funds Management LLC | 8,713,000 19.990% | 8,316,000 (+2094.71%) | Filing History |
| 2026-01-12 4:06 pm Purchase | 2025-11-10 | 13G | DAMORA THERAPEUTICS, INC DMRA | Paramora Holding LLC | 120,473 7.500% | 120,473 (New Position) | Filing History |
| 2026-01-12 4:01 pm Purchase | 2025-11-10 | 13G | DAMORA THERAPEUTICS, INC DMRA | Paragon Therapeutics, Inc. | 120,473 7.500% | 120,473 (New Position) | Filing History |
| 2025-12-05 4:50 pm Purchase | 2025-11-30 | 13G | GALECTO INC GLTO | Ikarian Capital, LLC | 285,710 21.500% | 285,710 (New Position) | Filing History |
| 2025-12-05 1:50 pm Purchase | 2025-11-28 | 13G | DAMORA THERAPEUTICS, INC DMRA | FMR LLC | 238,878 15.000% | 238,878 (New Position) | Filing History |
| 2025-11-17 9:45 pm Purchase | 2025-11-10 | 13D | DAMORA THERAPEUTICS, INC DMRA | Fairmount Funds Management LLC | 397,000 19.990% | 397,000 (New Position) | Filing History |
| 2025-11-13 5:26 pm Purchase | 2025-11-12 | 13G | DAMORA THERAPEUTICS, INC DMRA | Point72 Asset Management, L.P. | 100,001 6.300% | 100,001 (New Position) | Filing History |
| 2025-10-09 4:29 pm Sale | 2025-10-07 | 13D | GALECTO INC GLTO | Novo Holdings A/S | 0 0.000% | -86,579 (Position Closed) | Filing History |
| 2025-09-25 4:49 pm Sale | 2025-09-23 | 13D | GALECTO INC GLTO | Novo Holdings A/S | 86,579 6.500% | -13,334 (-13.35%) | Filing History |
| 2025-01-16 9:43 pm Purchase | 2024-08-29 | 13D | GALECTO INC GLTO | Novo Holdings A/S | 99,913 7.600% | 1 (+0.00%) | Filing History |
| 2024-11-07 3:07 pm Sale | 2024-09-30 | 13G | DAMORA THERAPEUTICS, INC DMRA | Sunstone Life Science Ventures A/S | 29,517 2.400% | -1,446,285 (-98.00%) | Filing History |